Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Oct-24 5:32 PM View:  | Anderman Todd Chief Legal Officer | Ocular Therapeutix, Inc (OCUL) | 07-Oct-24 | Grant | 98,700 | -- | -- | 100% 0 to 98.7K | |
| 04-Oct-24 5:21 PM View: | Kaiser Peter Chief Development Officer | Ocular Therapeutix, Inc (OCUL) | 02-Oct-24 | Grant | 100,000 | -- | -- | 86% 115.98K to 215.98K | |
| 04-Oct-24 5:20 PM View: | Heier Jeffrey S. Chief Scientific Officer | Ocular Therapeutix, Inc (OCUL) | 02-Oct-24 | Grant | 100,000 | -- | -- | 58% 172.01K to 272.01K | |
| 03-Sep-24 4:08 PM View: | Notman Donald See Remarks | Ocular Therapeutix, Inc (OCUL) | 29-Aug-24 | Grant | 11,034 | -- | -- | 6% 197.95K to 208.99K | |
| 27-Aug-24 5:19 PM View: | Nayak Sanjay Chief Strategy Officer | Ocular Therapeutix, Inc (OCUL) | 23-Aug-24 | Private Sale | 1,832 | $9.02 | $16,524.60 | (1%) 178.03K to 176.19K | |
| 27-Aug-24 5:17 PM View: | Dugel Pravin See Remarks Director | Ocular Therapeutix, Inc (OCUL) | 23-Aug-24 | Private Sale | 20,880 | $9.02 | $188,338.00 | (3%) 833.35K to 812.47K | |
| 26-Jul-24 6:39 PM View: | Warden Charles M Director | Ocular Therapeutix, Inc (OCUL) | 24-Jul-24 | Grant | 12,000 | -- | -- | 20% 60.46K to 72.46K | |
| 26-Jul-24 6:41 PM View: | Hong Seung Suh Director | Ocular Therapeutix, Inc (OCUL) | 24-Jul-24 | Grant | 12,000 | -- | -- | 57% 20.93K to 32.93K | |
| 26-Jul-24 6:40 PM View: | Raines Merilee Director | Ocular Therapeutix, Inc (OCUL) | 24-Jul-24 | Grant | 12,000 | -- | -- | 57% 20.93K to 32.93K | |
| 26-Jul-24 7:30 PM View: | Lindstrom Richard L Md Director | Ocular Therapeutix, Inc (OCUL) | 24-Jul-24 | Grant | 12,000 | -- | -- | 8% 150.7K to 162.7K | |
| 26-Jul-24 6:40 PM View: | Williams Leslie J. Director | Ocular Therapeutix, Inc (OCUL) | 24-Jul-24 | Grant | 12,000 | -- | -- | 47% 25.43K to 37.43K | |
| 26-Jul-24 6:38 PM View: | Graves Adrienne L Director | Ocular Therapeutix, Inc (OCUL) | 24-Jul-24 | Grant | 12,000 | -- | -- | 50% 24.0K to 36.0K | |
| 04-Jun-24 5:28 PM View: | Waheed Nadia Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 01-Jun-24 | Grant | 141,666 | -- | -- | 100% 0 to 141.67K | |
| 28-May-24 5:01 PM View: | Nayak Sanjay Chief Strategy Officer | Ocular Therapeutix, Inc (OCUL) | 23-May-24 | Market Sale | 2,274 | $5.84 | $13,280.20 | (1%) 180.3K to 178.03K | (11%) |
| 28-May-24 5:00 PM View: | Dugel Pravin See Remarks Director | Ocular Therapeutix, Inc (OCUL) | 23-May-24 | Market Sale | 21,626 | $5.79 | $125,215.00 | (3%) 854.98K to 833.35K | (12%) |
| 26-Jul-24 7:30 PM View: | Lindstrom Richard L Md Director | Ocular Therapeutix, Inc (OCUL) | 27-Feb-24 | Option Exercise | 30,302 | $8.80 | $266,658.00 | 25% 120.4K to 150.7K | |
| 27-Feb-24 4:43 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 26-Feb-24 | Purchase | 930,851 | $7.52 | $7,000,000.00 | 12% 7.66M to 8.59M | |
| 26-Feb-24 8:06 PM View: | Nayak Sanjay Chief Strategy Officer | Ocular Therapeutix, Inc (OCUL) | 22-Feb-24 | Grant | 80,300 | -- | -- | 80% 100.0K to 180.3K | |
| 26-Feb-24 8:07 PM View: | Dugel Pravin Executive Chairman Director | Ocular Therapeutix, Inc (OCUL) | 22-Feb-24 | Grant | 854,979 | -- | -- | 100% 0 to 854.98K | |
| 06-Feb-24 6:26 PM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 05-Feb-24 | Sale | 19,642 | $4.86 | $95,460.10 | 3% 575.56K to 595.2K | |
| 06-Feb-24 6:35 PM View: | Strassburger Philip C. General Counsel | Ocular Therapeutix, Inc (OCUL) | 05-Feb-24 | Sale | 6,029 | $4.86 | $29,300.90 | 4% 155.46K to 161.49K | |
| 06-Feb-24 6:38 PM View: | White Christopher G Chief Business Officer | Ocular Therapeutix, Inc (OCUL) | 05-Feb-24 | Sale | 5,910 | $4.86 | $28,722.60 | 5% 117.78K to 123.69K | |
| 06-Feb-24 6:29 PM View: | Notman Donald Chief Financial Officer | Ocular Therapeutix, Inc (OCUL) | 05-Feb-24 | Sale | 6,212 | $4.86 | $30,190.30 | 3% 189.14K to 195.36K | |
| 06-Feb-24 6:32 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 05-Feb-24 | Sale | 6,346 | $4.86 | $30,841.60 | 4% 146.71K to 153.05K | |
| 06-Feb-24 6:32 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 03-Feb-24 | Grant | 66,633 | -- | -- | 72% 92.77K to 159.4K | |
| 06-Feb-24 6:26 PM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 03-Feb-24 | Grant | 180,400 | -- | -- | 42% 434.44K to 614.84K | |
| 06-Feb-24 6:35 PM View: | Strassburger Philip C. General Counsel | Ocular Therapeutix, Inc (OCUL) | 03-Feb-24 | Grant | 58,304 | -- | -- | 53% 109.22K to 167.52K | |
| 06-Feb-24 6:38 PM View: | White Christopher G Chief Business Officer | Ocular Therapeutix, Inc (OCUL) | 03-Feb-24 | Grant | 39,980 | -- | -- | 45% 89.62K to 129.6K | |
| 06-Feb-24 6:29 PM View: | Notman Donald Chief Financial Officer | Ocular Therapeutix, Inc (OCUL) | 03-Feb-24 | Grant | 61,636 | -- | -- | 44% 139.93K to 201.57K | |
| 02-Feb-24 7:03 PM View: | Notman Donald Chief Financial Officer | Ocular Therapeutix, Inc (OCUL) | 31-Jan-24 | Sale | 6,433 | $4.95 | $31,843.30 | (4%) 146.37K to 139.93K | |
| 02-Feb-24 7:02 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 31-Jan-24 | Sale | 7,764 | $4.95 | $38,431.80 | (8%) 100.53K to 92.77K | |
| 02-Feb-24 7:00 PM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 31-Jan-24 | Sale | 18,338 | $4.95 | $90,773.10 | (4%) 452.78K to 434.44K | |
| 02-Feb-24 7:01 PM View: | Strassburger Philip C. General Counsel | Ocular Therapeutix, Inc (OCUL) | 31-Jan-24 | Sale | 6,831 | $4.95 | $33,813.40 | (6%) 116.05K to 109.22K | |
| 02-Feb-24 7:01 PM View: | White Christopher G Chief Business Officer | Ocular Therapeutix, Inc (OCUL) | 31-Jan-24 | Sale | 5,147 | $4.95 | $25,477.60 | (5%) 94.77K to 89.62K | |
| 18-Dec-23 4:52 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 14-Dec-23 | Private Purchase | 1,538,460 | $3.25 | $5,000,000.00 | 25% 6.12M to 7.66M | |
| 05-Sep-23 8:27 AM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 30-Aug-23 | Private Purchase | 6,500 | $3.81 | $24,765.00 | 1% 446.28K to 452.78K | |
| 12-Jul-23 5:18 PM View: | Graves Adrienne L Director | Ocular Therapeutix, Inc (OCUL) | 10-Jul-23 | Grant | 24,000 | -- | -- | 100% 0 to 24.0K | |
| 11-Jul-23 8:00 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 07-Jul-23 | Sale | 832 | $4.93 | $4,101.76 | (< 1%) 101.36K to 100.53K | |
| 08-Feb-23 7:29 PM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 06-Feb-23 | Sale (Planned) | 19,669 | $4.24 | $83,396.60 | (4%) 465.95K to 446.28K | |
| 08-Feb-23 7:31 PM View: | Strassburger Philip C. General Counsel | Ocular Therapeutix, Inc (OCUL) | 06-Feb-23 | Sale (Planned) | 6,181 | $4.24 | $26,207.40 | (5%) 115.25K to 109.07K | |
| 08-Feb-23 7:38 PM View: | White Christopher G Chief Business Officer | Ocular Therapeutix, Inc (OCUL) | 06-Feb-23 | Sale (Planned) | 5,829 | $4.24 | $24,715.00 | (6%) 100.59K to 94.77K | |
| 08-Feb-23 7:32 PM View: | Notman Donald Chief Financial Officer | Ocular Therapeutix, Inc (OCUL) | 06-Feb-23 | Sale (Planned) | 6,476 | $4.24 | $27,458.20 | (4%) 145.86K to 139.39K | |
| 08-Feb-23 7:33 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 06-Feb-23 | Sale (Planned) | 6,416 | $4.24 | $27,203.80 | (6%) 107.78K to 101.36K | |
| 01-Feb-23 7:33 PM View: | Notman Donald Chief Financial Officer | Ocular Therapeutix, Inc (OCUL) | 30-Jan-23 | Grant | 55,556 | -- | -- | 62% 90.31K to 145.86K | |
| 01-Feb-23 7:34 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 30-Jan-23 | Grant | 55,556 | -- | -- | 106% 52.22K to 107.78K | |
| 01-Feb-23 7:32 PM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 30-Jan-23 | Grant | 176,300 | -- | -- | 61% 289.65K to 465.95K | |
| 01-Feb-23 7:35 PM View: | Strassburger Philip C. General Counsel | Ocular Therapeutix, Inc (OCUL) | 30-Jan-23 | Grant | 55,556 | -- | -- | 93% 59.7K to 115.25K | |
| 01-Feb-23 7:36 PM View: | White Christopher G Chief Business Officer | Ocular Therapeutix, Inc (OCUL) | 30-Jan-23 | Grant | 44,444 | -- | -- | 79% 56.15K to 100.59K | |
| 09-Nov-22 4:48 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 07-Nov-22 | Private Purchase | 7,328 | $3.50 | $25,648.00 | < 1% 6.11M to 6.12M | |
| 12-Oct-22 4:34 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 11-Oct-22 | Purchase | 10,000 | $3.90 | $38,993.00 | < 1% 6.1M to 6.11M |
